US Antibody Engineering Xchange
Philadelphia, March 13, 2018

Welcome to hubXchange’s US Antibody Engineering Xchange 2018, bringing together executives from pharma and biotech as well as thought leaders from academia to address and find solutions to the key issues faced in engineering antibodies.

Take advantage of this unique highly interactive meeting format designed for maximum engagement, collaboration and networking with your peers.

Confirmed Facilitators include:

• Hanspeter Gerber, President & Chief Scientific Officer, Maverick Therapeutics
• Clark Pan, Vice President, Head of Discovery Therapeutics, Shire
• Paul Moore, Vice President, Research, MacroGenics
• Theresa Goletz, Global Head, NBE Drug Disposition, EMD Serono
• Chung-Ming Hsieh, Executive Director, Biologics Discovery, Merck
• Marc Damelin, Senior Director, Head of Biology, Mersana Therapeutics
• Partha Chowdhury, Senior Director & Head, Antibody Discovery, Sanofi
• Changshou Gao, Senior Director & Fellow, R&D, MedImmune
• Huawei Qiu, Senior Director, Head of Protein Engineering, Sanofi
• Edward Berger, Chief, Molecular Structure Section, National Institutes of Health
• Michael Sierks, Professor, Chemical Engineering, Arizona State University
• Horacio Nastri, Senior Director, Antibody Biotherapeutics, Incyte Corporation
• Zhinan Xia, Senior Director, Henlix
• Dowdy Jackson, Director, Biological Sciences, Ambrx

Partners

Gold Sponsor

Silver Sponsors

Bronze Sponsors

Venue

Doubletree by Hilton, Philadelphia Airport
4509 Island Avenue, Philadelphia, PA 19153
TEL: +1-215-365-4150

Register